Publications by authors named "Vanessa Taieb"

Claim this Profile
S
Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies.
Helena Marzo-Ortega, Victoria Navarro-Compan, Maureen Dubreuil, Philip J Mease, Marina Magrey, Vanessa Taieb

RMD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained resolution of enthesitis and peripheral arthritis over 104 weeks with bimekizumab in axial spondyloarthritis.
Sofia Ramiro, Denis Poddubnyy, Philip J Mease, Clementina López-Medina, Mindy Kim, Vanessa Taieb

RMD Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Use of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistence, and Dosing Variations.
Maureen Dubreuil, Jessica A Walsh, Atul Deodhar, Lianne S Gensler, Jeffrey R Curtis, Vanessa Taieb

Pharmacoepidemiol Drug Saf· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies.
Victoria Navarro-Compán, Martin Rudwaleit, Maureen Dubreuil, Marina Magrey, Helena Marzo-Ortega, Vanessa Taieb

J Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis.
Richard B Warren, Kerry Donnelly, Sandeep Kiri, Vanessa Taieb, Mahmoud Slim

Dermatol Ther (Heidelb)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies.
Lars Erik Kristensen, William Tillett, Peter Nash, Laura C Coates, Philip J Mease, Vanessa Taieb

Ther Adv Musculoskelet Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Philip J Mease, Richard B Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Vanessa Taieb

Rheumatol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Philip J Mease, Richard B Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Vanessa Taieb

Rheumatol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies.
Laure Gossec, Ana-Maria Orbai, Maarten de Wit, Laura C Coates, Alexis Ogdie, Vanessa Taieb

Rheumatology (Oxford)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies.
M Elaine Husni, Philip J Mease, Joseph F Merola, William Tillett, Nadine Goldammer, Vanessa Taieb

RMD Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis.
Walter P Maksymowych, Howard Thom, Michael F Mørup, Vanessa Taieb, Damon Willems

Rheumatol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
Philip J Mease, Dafna D Gladman, Joseph F Merola, Peter Nash, Stacy Grieve, Vanessa Taieb

Rheumatology (Oxford)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
Philip J Mease, Richard B Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Vanessa Taieb

Rheumatol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Richard B Warren, Iain B McInnes, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Vanessa Taieb

Rheumatol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies.
Maureen Dubreuil, Victoria Navarro-Compán, Annelies Boonen, Karl Gaffney, Lianne S Gensler, Vanessa Taieb

RMD Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis.
Atul Deodhar, Pedro M Machado, Michael Mørup, Vanessa Taieb, Damon Willems

Rheumatology (Oxford)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland.
Michael F Mørup, Vanessa Taieb, Damon Willems, Micah Rose, Nikos Lyris

J Med Econ· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2.
Victoria Navarro-Compán, Sofia Ramiro, Atul Deodhar, Philip J Mease, Martin Rudwaleit, Vanessa Taieb

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.
Laure Gossec, Brittany Humphries, Megan Rutherford, Vanessa Taieb, Damon Willems

Arthritis Res Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
Laure Gossec, Ana-Maria Orbai, Laura C Coates, Dafna D Gladman, Alexis Ogdie, Vanessa Taieb

RMD Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis.
Martin Rudwaleit, Michael F Mørup, Brittany Humphries, Noor-E Zannat, Damon Willems, Vanessa Taieb

RMD Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis.
Martin Rudwaleit, Pedro M Machado, Vanessa Taieb, Natasha de Peyrecave, Bengt Hoepken

Ther Adv Musculoskelet Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis.
William Tillett, Laura C Coates, Sandeep Kiri, Vanessa Taieb, Damon Willems

Ther Adv Musculoskelet Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study.
Philip C Robinson, Pedro M Machado, Nigil Haroon, Lianne S Gensler, John D Reveille, Vanessa Taieb

ACR Open Rheumatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis.
April Armstrong, Kyle Fahrbach, Craig Leonardi, Matthias Augustin, Binod Neupane, Vanessa Taieb

Dermatol Ther (Heidelb)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis